Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Clinics in Laboratory Medicine
|
April 10, 2007
Assessing hERG channel inhibition using PatchXpress
Justin Q Ly, Gordon Shyy, Dinah L Misner
Pharmacology & Therapeutics
|
February 25, 2015
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
Deepak Sampath, Tanja S Zabka, Dinah L Misner, et al.
The European Journal of Neuroscience
|
August 16, 2008
Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice
Kris Rutten, Dinah L Misner, Melissa Works, et al.
Neuropharmacology
|
April 5, 2011
Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B-/-) mice
Kris Rutten, Tanya L Wallace, Melissa Works, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 9, 2007
3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists
Shu-Hai Zhao, Jacob Berger, Robin D Clark, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 27, 2007
Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice
Maria Bjarnadottir, Dinah L Misner, Sascha Haverfield-Gross, et al.
Toxicology Mechanisms and Methods
|
April 21, 2015
Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid
Jacqueline M Tarrant, Preeti Dhawan, Jatinder Singh, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 16, 2014
Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase
Tanja S Zabka, Jatinder Singh, Preeti Dhawan, et al.
Journal of Medicinal Chemistry
|
September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH
Koen Vandyck, David C McGowan, Xuan G Luong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 9, 2016
Bruton's Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats
Rebecca I Erickson, Leah K Schutt, Jacqueline M Tarrant, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Clinics in Laboratory Medicine
|
April 10, 2007
Assessing hERG channel inhibition using PatchXpress
Justin Q Ly, Gordon Shyy, Dinah L Misner
Pharmacology & Therapeutics
|
February 25, 2015
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
Deepak Sampath, Tanja S Zabka, Dinah L Misner, et al.
The European Journal of Neuroscience
|
August 16, 2008
Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice
Kris Rutten, Dinah L Misner, Melissa Works, et al.
Neuropharmacology
|
April 5, 2011
Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B-/-) mice
Kris Rutten, Tanya L Wallace, Melissa Works, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 9, 2007
3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists
Shu-Hai Zhao, Jacob Berger, Robin D Clark, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 27, 2007
Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice
Maria Bjarnadottir, Dinah L Misner, Sascha Haverfield-Gross, et al.
Toxicology Mechanisms and Methods
|
April 21, 2015
Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid
Jacqueline M Tarrant, Preeti Dhawan, Jatinder Singh, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 16, 2014
Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase
Tanja S Zabka, Jatinder Singh, Preeti Dhawan, et al.
Journal of Medicinal Chemistry
|
September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH
Koen Vandyck, David C McGowan, Xuan G Luong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 9, 2016
Bruton's Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats
Rebecca I Erickson, Leah K Schutt, Jacqueline M Tarrant, et al.
Page
of 2